-
1
-
-
33644597912
-
Incidence of venous thromboembolism and its effect on survival among patients with common cancers
-
Chew H.K., Wun T., Harvey D., Zhou H., White R.H. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Archives of Internal Medicine 2006, 166:458-464.
-
(2006)
Archives of Internal Medicine
, vol.166
, pp. 458-464
-
-
Chew, H.K.1
Wun, T.2
Harvey, D.3
Zhou, H.4
White, R.H.5
-
2
-
-
63049128736
-
-
American Society of Clinical Oncology; Cancer Thromb, p. 240-8. Available at:
-
Khorana A.A., Liebman H.A., White R.H., Wun T., Lyman G.H. The risk of venous thromboembolism in patients with cancer 2008, American Society of Clinical Oncology; Cancer Thromb, p. 240-8. Available at: http://www.asco.org/ASCOv2/Home/Education%20and%20Training/Educational%20Book/PDF%20Files/2008/hsr01.pdf.
-
(2008)
The risk of venous thromboembolism in patients with cancer
-
-
Khorana, A.A.1
Liebman, H.A.2
White, R.H.3
Wun, T.4
Lyman, G.H.5
-
3
-
-
34648864383
-
Incidence of venous thromboembolism and the impact on survival in breast cancer patients
-
Chew H.K., Wun T., Harvey D.J., Zhou H., White R.H. Incidence of venous thromboembolism and the impact on survival in breast cancer patients. Journal of Clinical Oncology 2007, 25:70-76.
-
(2007)
Journal of Clinical Oncology
, vol.25
, pp. 70-76
-
-
Chew, H.K.1
Wun, T.2
Harvey, D.J.3
Zhou, H.4
White, R.H.5
-
4
-
-
33644981137
-
Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival
-
Alcalay A., Wun T., Khatri V., et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. Journal of Clinical Oncology 2006, 24:1112-1118.
-
(2006)
Journal of Clinical Oncology
, vol.24
, pp. 1112-1118
-
-
Alcalay, A.1
Wun, T.2
Khatri, V.3
-
5
-
-
0034700438
-
Prognosis of cancers associated with venous thromboembolism
-
Sorensen H.T., Mellemkjaer L., Olsen J.H., Baron J.A. Prognosis of cancers associated with venous thromboembolism. New England Journal of Medicine 2000, 343:1846-1850.
-
(2000)
New England Journal of Medicine
, vol.343
, pp. 1846-1850
-
-
Sorensen, H.T.1
Mellemkjaer, L.2
Olsen, J.H.3
Baron, J.A.4
-
7
-
-
34247568441
-
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
-
Khorana A.A., Francis C.W., Culakova E., Kuderer N.M., Lyman G.H. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. Journal of Thrombosis and Haemostasis 2007, 5:632-634.
-
(2007)
Journal of Thrombosis and Haemostasis
, vol.5
, pp. 632-634
-
-
Khorana, A.A.1
Francis, C.W.2
Culakova, E.3
Kuderer, N.M.4
Lyman, G.H.5
-
10
-
-
13444256137
-
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
-
Blom J.W., Doggen C.J., Osanto S., Rosendaal F.R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005, 293:715-722.
-
(2005)
JAMA
, vol.293
, pp. 715-722
-
-
Blom, J.W.1
Doggen, C.J.2
Osanto, S.3
Rosendaal, F.R.4
-
11
-
-
0037111563
-
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
-
Prandoni P., Lensing A.W., Piccioli A., et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002, 100:3484-3488.
-
(2002)
Blood
, vol.100
, pp. 3484-3488
-
-
Prandoni, P.1
Lensing, A.W.2
Piccioli, A.3
-
12
-
-
36049000503
-
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
-
Khorana A.A., Francis C.W., Culakova E., Kuderer N.M., Lyman G.H. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 2007, 110:2339-2346.
-
(2007)
Cancer
, vol.110
, pp. 2339-2346
-
-
Khorana, A.A.1
Francis, C.W.2
Culakova, E.3
Kuderer, N.M.4
Lyman, G.H.5
-
13
-
-
29144486069
-
Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study
-
Khorana A.A., Francis C.W., Culakova E., Lyman G.H. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer 2005, 104:2822-2829.
-
(2005)
Cancer
, vol.104
, pp. 2822-2829
-
-
Khorana, A.A.1
Francis, C.W.2
Culakova, E.3
Lyman, G.H.4
-
14
-
-
78650055834
-
Prediction of venous thromboembolism in cancer patients
-
Ay C., Dunkler D., Marosi C., et al. Prediction of venous thromboembolism in cancer patients. Blood 2010, 116:5377-5382.
-
(2010)
Blood
, vol.116
, pp. 5377-5382
-
-
Ay, C.1
Dunkler, D.2
Marosi, C.3
-
15
-
-
0942265619
-
Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon
-
Otten H.M., Mathijssen J., ten Cate H., et al. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Archives of Internal Medicine 2004, 164:190-194.
-
(2004)
Archives of Internal Medicine
, vol.164
, pp. 190-194
-
-
Otten, H.M.1
Mathijssen, J.2
ten Cate, H.3
-
16
-
-
0032935334
-
The thrombophilic state induced by therapeutic agents in the cancer patient
-
Lee A.Y., Levine M.N. The thrombophilic state induced by therapeutic agents in the cancer patient. Seminars in Thrombosis and Hemostasis 1999, 25:137-145.
-
(1999)
Seminars in Thrombosis and Hemostasis
, vol.25
, pp. 137-145
-
-
Lee, A.Y.1
Levine, M.N.2
-
18
-
-
40349103260
-
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
-
Bennett C.L., Silver S.M., Djulbegovic B., et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 2008, 299:914-924.
-
(2008)
JAMA
, vol.299
, pp. 914-924
-
-
Bennett, C.L.1
Silver, S.M.2
Djulbegovic, B.3
-
19
-
-
0141452131
-
Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin
-
Wun T., Law L., Harvey D., Sieracki B., Scudder S.A., Ryu J.K. Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin. Cancer 2003, 98:1514-1520.
-
(2003)
Cancer
, vol.98
, pp. 1514-1520
-
-
Wun, T.1
Law, L.2
Harvey, D.3
Sieracki, B.4
Scudder, S.A.5
Ryu, J.K.6
-
20
-
-
33646905411
-
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients
-
Bohlius J., Wilson J., Seidenfeld J., et al. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. Journal of the National Cancer Institute 2006, 98:708-714.
-
(2006)
Journal of the National Cancer Institute
, vol.98
, pp. 708-714
-
-
Bohlius, J.1
Wilson, J.2
Seidenfeld, J.3
-
21
-
-
34147207484
-
Venous thromboembolism and survival in patients with high-grade glioma
-
Simanek R., Vormittag R., Hassler M., et al. Venous thromboembolism and survival in patients with high-grade glioma. Neurooncology 2007, 9:89-95.
-
(2007)
Neurooncology
, vol.9
, pp. 89-95
-
-
Simanek, R.1
Vormittag, R.2
Hassler, M.3
-
22
-
-
33645996692
-
Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study
-
Blom J.W., Vanderschoot J.P., Oostindier M.J., Osanto S., van der Meer F.J., Rosendaal F.R. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. Journal of Thrombosis and Haemostasis 2006, 4:529-535.
-
(2006)
Journal of Thrombosis and Haemostasis
, vol.4
, pp. 529-535
-
-
Blom, J.W.1
Vanderschoot, J.P.2
Oostindier, M.J.3
Osanto, S.4
van der Meer, F.J.5
Rosendaal, F.R.6
-
23
-
-
84884140311
-
-
Thrombose und Embolie. Gefässentzündung und septische Infektion [Gesammelte Abhandlungen zur wissenschaftlichen Medicin]. Frankfurt am Main: Von Meidinger & Son; [English translation by Matzdorff AC, Bell WR, in Thrombosis and Emboli. Canton, MA: Science History Publications, 1998; in German]
-
Virchow RLK. Thrombose und Embolie. Gefässentzündung und septische Infektion [Gesammelte Abhandlungen zur wissenschaftlichen Medicin]. Frankfurt am Main: Von Meidinger & Son; 1856, p. 219-732 [English translation by Matzdorff AC, Bell WR, in Thrombosis and Emboli. Canton, MA: Science History Publications, 1998; in German].
-
(1856)
, pp. 219-732
-
-
Virchow, R.L.K.1
-
24
-
-
0019503942
-
A factor X-activating cysteine protease from malignant tissue
-
Gordon S.G., Cross B.A. A factor X-activating cysteine protease from malignant tissue. Journal of Clinical Investigation 1981, 67:1665-1671.
-
(1981)
Journal of Clinical Investigation
, vol.67
, pp. 1665-1671
-
-
Gordon, S.G.1
Cross, B.A.2
-
25
-
-
33845781028
-
From Trousseau to angiogenesis: the link between the haemostatic system and cancer
-
Nijziel M.R., van Oerle R., Hillen H.F., Hamulyak K. From Trousseau to angiogenesis: the link between the haemostatic system and cancer. Netherlands Journal of Medicine 2006, 64:403-410.
-
(2006)
Netherlands Journal of Medicine
, vol.64
, pp. 403-410
-
-
Nijziel, M.R.1
van Oerle, R.2
Hillen, H.F.3
Hamulyak, K.4
-
26
-
-
0036858410
-
The hypercoagulable state of malignancy: pathogenesis and current debate
-
Caine G.J., Stonelake P.S., Lip G.Y., Kehoe S.T. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 2002, 4:465-473.
-
(2002)
Neoplasia
, vol.4
, pp. 465-473
-
-
Caine, G.J.1
Stonelake, P.S.2
Lip, G.Y.3
Kehoe, S.T.4
-
27
-
-
0037362704
-
Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets
-
Muller I., Klocke A., Alex M., et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB Journal 2003, 17:476-478.
-
(2003)
FASEB Journal
, vol.17
, pp. 476-478
-
-
Muller, I.1
Klocke, A.2
Alex, M.3
-
28
-
-
0037391809
-
Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein
-
Bogdanov V.Y., Balasubramanian V., Hathcock J., Vele O., Lieb M., Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nature Medicine 2003, 9:458-462.
-
(2003)
Nature Medicine
, vol.9
, pp. 458-462
-
-
Bogdanov, V.Y.1
Balasubramanian, V.2
Hathcock, J.3
Vele, O.4
Lieb, M.5
Nemerson, Y.6
-
29
-
-
60449118289
-
Circulating procoagulant microparticles in patients with venous thromboembolism
-
Ay C., Freyssinet J.M., Sailer T., Vormittag R., Pabinger I. Circulating procoagulant microparticles in patients with venous thromboembolism. Thrombosis Research 2009, 123:724-726.
-
(2009)
Thrombosis Research
, vol.123
, pp. 724-726
-
-
Ay, C.1
Freyssinet, J.M.2
Sailer, T.3
Vormittag, R.4
Pabinger, I.5
-
30
-
-
43749093560
-
Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients
-
Tilley R.E., Holscher T., Belani R., Nieva J., Mackman N. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thrombosis Research 2008, 122:604-609.
-
(2008)
Thrombosis Research
, vol.122
, pp. 604-609
-
-
Tilley, R.E.1
Holscher, T.2
Belani, R.3
Nieva, J.4
Mackman, N.5
-
32
-
-
0027162435
-
C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
-
Cermak J., Key N.S., Bach R.R., Balla J., Jacob H.S., Vercellotti G.M. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993, 82:513-520.
-
(1993)
Blood
, vol.82
, pp. 513-520
-
-
Cermak, J.1
Key, N.S.2
Bach, R.R.3
Balla, J.4
Jacob, H.S.5
Vercellotti, G.M.6
-
33
-
-
24344490417
-
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation
-
Cirillo P., Golino P., Calabro P., et al. C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovascular Research 2005, 68:47-55.
-
(2005)
Cardiovascular Research
, vol.68
, pp. 47-55
-
-
Cirillo, P.1
Golino, P.2
Calabro, P.3
-
34
-
-
60649120010
-
C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo
-
Devaraj S., Dasu M.R., Singh U., Rao L.V., Jialal I. C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo. Atherosclerosis 2009, 203:67-74.
-
(2009)
Atherosclerosis
, vol.203
, pp. 67-74
-
-
Devaraj, S.1
Dasu, M.R.2
Singh, U.3
Rao, L.V.4
Jialal, I.5
-
35
-
-
12444303861
-
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin
-
Falati S., Liu Q., Gross P., et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. Journal of Experimental Medicine 2003, 197:1585-1598.
-
(2003)
Journal of Experimental Medicine
, vol.197
, pp. 1585-1598
-
-
Falati, S.1
Liu, Q.2
Gross, P.3
-
36
-
-
0034678355
-
P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo
-
Frenette P.S., Denis C.V., Weiss L., et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. Journal of Experimental Medicine 2000, 191:1413-1422.
-
(2000)
Journal of Experimental Medicine
, vol.191
, pp. 1413-1422
-
-
Frenette, P.S.1
Denis, C.V.2
Weiss, L.3
-
37
-
-
61549101213
-
Biomarkers and venous thromboembolism
-
Pabinger I., Ay C. Biomarkers and venous thromboembolism. Arteriosclerosis, Thrombosis, and Vascular Biology 2009, 29:332-336.
-
(2009)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.29
, pp. 332-336
-
-
Pabinger, I.1
Ay, C.2
-
38
-
-
78650952222
-
Thrombosis risk and survival in cancer patients with elevated C-reactive protein
-
Kanz R., Vukovich T., Vormittag R., et al. Thrombosis risk and survival in cancer patients with elevated C-reactive protein. Journal of Thrombosis and Haemostasis 2011, 9:57-63.
-
(2011)
Journal of Thrombosis and Haemostasis
, vol.9
, pp. 57-63
-
-
Kanz, R.1
Vukovich, T.2
Vormittag, R.3
-
39
-
-
57549119306
-
C-reactive protein isoforms differ in their effects on thrombus growth
-
Molins B., Pena E., Vilahur G., Mendieta C., Slevin M., Badimon L. C-reactive protein isoforms differ in their effects on thrombus growth. Arteriosclerosis, Thrombosis, and Vascular Biology 2008, 28:2239-2246.
-
(2008)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.28
, pp. 2239-2246
-
-
Molins, B.1
Pena, E.2
Vilahur, G.3
Mendieta, C.4
Slevin, M.5
Badimon, L.6
-
41
-
-
0035876016
-
Molecular basis for the relationship between thrombosis and cancer
-
Rickles F.R., Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thrombosis Research 2001, 102:V215-V224.
-
(2001)
Thrombosis Research
, vol.102
-
-
Rickles, F.R.1
Falanga, A.2
-
42
-
-
67349180253
-
Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication
-
Koukourakis M.I., Kambouromiti G., Pitsiava D., Tsousou P., Tsiarkatsi M., Kartalis G. Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication. Inflammation 2009, 32:169-175.
-
(2009)
Inflammation
, vol.32
, pp. 169-175
-
-
Koukourakis, M.I.1
Kambouromiti, G.2
Pitsiava, D.3
Tsousou, P.4
Tsiarkatsi, M.5
Kartalis, G.6
-
43
-
-
15344346732
-
Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism
-
Vormittag R., Vukovich T., Schonauer V., et al. Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism. Thrombosis and Haemostasis 2005, 93:488-493.
-
(2005)
Thrombosis and Haemostasis
, vol.93
, pp. 488-493
-
-
Vormittag, R.1
Vukovich, T.2
Schonauer, V.3
-
44
-
-
31544478042
-
Risk factors for venous thromboembolic events in cancer patients
-
Kroger K., Weiland D., Ose C., et al. Risk factors for venous thromboembolic events in cancer patients. Annals of Oncology 2006, 17:297-303.
-
(2006)
Annals of Oncology
, vol.17
, pp. 297-303
-
-
Kroger, K.1
Weiland, D.2
Ose, C.3
-
45
-
-
70249119693
-
D-dimer and prothrombin fragment 1+2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study
-
Ay C., Vormittag R., Dunkler D., et al. D-dimer and prothrombin fragment 1+2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. Journal of Clinical Oncology 2009, 27:4124-4129.
-
(2009)
Journal of Clinical Oncology
, vol.27
, pp. 4124-4129
-
-
Ay, C.1
Vormittag, R.2
Dunkler, D.3
-
46
-
-
0036235907
-
Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer
-
Kohli M., Fink L.M., Spencer H.J., Zent C.S. Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer. Blood Coagulation and Fibrinolysis 2002, 13:1-5.
-
(2002)
Blood Coagulation and Fibrinolysis
, vol.13
, pp. 1-5
-
-
Kohli, M.1
Fink, L.M.2
Spencer, H.J.3
Zent, C.S.4
-
47
-
-
0027276819
-
Prothrombin fragment F 1+2 plasma concentrations in patients with gynecologic malignancies
-
Hanzal E., Tatra G. Prothrombin fragment F 1+2 plasma concentrations in patients with gynecologic malignancies. Gynecologic Oncology 1993, 49:373-376.
-
(1993)
Gynecologic Oncology
, vol.49
, pp. 373-376
-
-
Hanzal, E.1
Tatra, G.2
-
48
-
-
0027400528
-
Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis
-
Seitz R., Rappe N., Kraus M., et al. Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis. Blood Coagulation and Fibrinolysis 1993, 4:249-254.
-
(1993)
Blood Coagulation and Fibrinolysis
, vol.4
, pp. 249-254
-
-
Seitz, R.1
Rappe, N.2
Kraus, M.3
-
49
-
-
77956907268
-
Elevated D-dimers are also a marker of underlying malignancy and increased mortality in the absence of venous thromboembolism
-
Knowlson L., Bacchu S., Paneesha S., McManus A., Randall K., Rose P. Elevated D-dimers are also a marker of underlying malignancy and increased mortality in the absence of venous thromboembolism. Journal of Clinical Pathology 2010, 63:818-822.
-
(2010)
Journal of Clinical Pathology
, vol.63
, pp. 818-822
-
-
Knowlson, L.1
Bacchu, S.2
Paneesha, S.3
McManus, A.4
Randall, K.5
Rose, P.6
-
50
-
-
45749130204
-
Elevated levels of prothrombin fragment 1+2 indicate high risk of thrombosis
-
Ota S., Wada H., Abe Y., et al. Elevated levels of prothrombin fragment 1+2 indicate high risk of thrombosis. Clinical and Applied Thrombosis and Hemostasis 2008, 14:279-285.
-
(2008)
Clinical and Applied Thrombosis and Hemostasis
, vol.14
, pp. 279-285
-
-
Ota, S.1
Wada, H.2
Abe, Y.3
-
51
-
-
0030982676
-
Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism
-
Kyrle P.A., Eichinger S., Pabinger I., et al. Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism. Thrombosis and Haemostasis 1997, 77:829-833.
-
(1997)
Thrombosis and Haemostasis
, vol.77
, pp. 829-833
-
-
Kyrle, P.A.1
Eichinger, S.2
Pabinger, I.3
-
52
-
-
2342439962
-
Clotting activation after oral anticoagulant therapy discontinuation: a risk factor for recurrent venous thromboembolism
-
Poli D., Antonucci E., Cecchi E., et al. Clotting activation after oral anticoagulant therapy discontinuation: a risk factor for recurrent venous thromboembolism. Blood Coagulation and Fibrinolysis 2004, 15:221-225.
-
(2004)
Blood Coagulation and Fibrinolysis
, vol.15
, pp. 221-225
-
-
Poli, D.1
Antonucci, E.2
Cecchi, E.3
-
53
-
-
79957517025
-
Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study
-
Ay C., Dunkler D., Simanek R., et al. Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study. Journal of Clinical Oncology 2011, 29:2099-2103.
-
(2011)
Journal of Clinical Oncology
, vol.29
, pp. 2099-2103
-
-
Ay, C.1
Dunkler, D.2
Simanek, R.3
-
54
-
-
53449093751
-
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
-
Ay C., Simanek R., Vormittag R., et al. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 2008, 112:2703-2708.
-
(2008)
Blood
, vol.112
, pp. 2703-2708
-
-
Ay, C.1
Simanek, R.2
Vormittag, R.3
-
55
-
-
33747508925
-
P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis
-
Chen M., Geng J.G. P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Archivum Immunologiae et Therapiae Experimentalis 2006, 54:75-84.
-
(2006)
Archivum Immunologiae et Therapiae Experimentalis
, vol.54
, pp. 75-84
-
-
Chen, M.1
Geng, J.G.2
-
56
-
-
3242791115
-
P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasis
-
Geng J.G., Chen M., Chou K.C. P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasis. Current Medicinal Chemistry 2004, 11:2153-2160.
-
(2004)
Current Medicinal Chemistry
, vol.11
, pp. 2153-2160
-
-
Geng, J.G.1
Chen, M.2
Chou, K.C.3
-
57
-
-
69549103137
-
Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo
-
Thomas G.M., Panicot-Dubois L., Lacroix R., Dignat-George F., Lombardo D., Dubois C. Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. Journal of Experimental Medicine 2009, 206:1913-1927.
-
(2009)
Journal of Experimental Medicine
, vol.206
, pp. 1913-1927
-
-
Thomas, G.M.1
Panicot-Dubois, L.2
Lacroix, R.3
Dignat-George, F.4
Lombardo, D.5
Dubois, C.6
-
58
-
-
73849086884
-
High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study
-
Vormittag R., Simanek R., Ay C., et al. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study. Arteriosclerosis, Thrombosis, and Vascular Biology 2009, 29:2176-2181.
-
(2009)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.29
, pp. 2176-2181
-
-
Vormittag, R.1
Simanek, R.2
Ay, C.3
-
59
-
-
56949088997
-
Relation between hemostatic parameters and prognostic/predictive factors in breast cancer
-
Yigit E., Gonullu G., Yucel I., Turgut M., Erdem D., Cakar B. Relation between hemostatic parameters and prognostic/predictive factors in breast cancer. European Journal of Internal Medicine 2008, 19:602-607.
-
(2008)
European Journal of Internal Medicine
, vol.19
, pp. 602-607
-
-
Yigit, E.1
Gonullu, G.2
Yucel, I.3
Turgut, M.4
Erdem, D.5
Cakar, B.6
-
61
-
-
0642341991
-
Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment
-
Minnema M.C., Fijnheer R., De Groot P.G., Lokhorst H.M. Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment. Journal of Thrombosis and Haemostasis 2003, 1:445-449.
-
(2003)
Journal of Thrombosis and Haemostasis
, vol.1
, pp. 445-449
-
-
Minnema, M.C.1
Fijnheer, R.2
De Groot, P.G.3
Lokhorst, H.M.4
-
62
-
-
33846483859
-
The effect of venous thromboembolism on survival of cancer patients and its relationship with serum levels of factor VIII and vascular endothelial growth factor: a prospective matched-paired study
-
Dogan M., Demirkazik A., Konuk N., et al. The effect of venous thromboembolism on survival of cancer patients and its relationship with serum levels of factor VIII and vascular endothelial growth factor: a prospective matched-paired study. International Journal of Biological Markers 2006, 21:206-210.
-
(2006)
International Journal of Biological Markers
, vol.21
, pp. 206-210
-
-
Dogan, M.1
Demirkazik, A.2
Konuk, N.3
-
63
-
-
77955504709
-
Predictive value of tissue factor bearing microparticles in cancer associated thrombosis
-
Zwicker J.I. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. Thrombosis Research 2010, 125(Suppl. 2):S89-S91.
-
(2010)
Thrombosis Research
, vol.125
, Issue.SUPPL. 2
-
-
Zwicker, J.I.1
-
64
-
-
34249806307
-
Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer
-
Khorana A.A., Ahrendt S.A., Ryan C.K., et al. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clinical Cancer Research 2007, 13:2870-2875.
-
(2007)
Clinical Cancer Research
, vol.13
, pp. 2870-2875
-
-
Khorana, A.A.1
Ahrendt, S.A.2
Ryan, C.K.3
-
66
-
-
34247606502
-
Microparticle-associated tissue factor activity: a link between cancer and thrombosis
-
Tesselaar M.E., Romijn F.P., Van Der Linden I., Prins F.A., Bertina R.M., Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis. Journal of Thrombosis and Haemostasis 2007, 5:520-527.
-
(2007)
Journal of Thrombosis and Haemostasis
, vol.5
, pp. 520-527
-
-
Tesselaar, M.E.1
Romijn, F.P.2
Van Der Linden, I.3
Prins, F.A.4
Bertina, R.M.5
Osanto, S.6
-
67
-
-
33846941576
-
Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer
-
Hron G., Kollars M., Weber H., et al. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thrombosis and Haemostasis 2007, 97:119-123.
-
(2007)
Thrombosis and Haemostasis
, vol.97
, pp. 119-123
-
-
Hron, G.1
Kollars, M.2
Weber, H.3
-
68
-
-
54149109726
-
Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer
-
Khorana A.A., Francis C.W., Menzies K.E., et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. Journal of Thrombosis and Haemostasis 2008, 6:1983-1985.
-
(2008)
Journal of Thrombosis and Haemostasis
, vol.6
, pp. 1983-1985
-
-
Khorana, A.A.1
Francis, C.W.2
Menzies, K.E.3
-
69
-
-
77952548349
-
Increased microparticle tissue factor activity in cancer patients with Venous thromboembolism
-
Manly D.A., Wang J., Glover S.L., et al. Increased microparticle tissue factor activity in cancer patients with Venous thromboembolism. Thrombosis Research 2010, 125:511-512.
-
(2010)
Thrombosis Research
, vol.125
, pp. 511-512
-
-
Manly, D.A.1
Wang, J.2
Glover, S.L.3
-
70
-
-
36048936310
-
Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?
-
White R.H., Chew H., Wun T. Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?. Thrombosis Research 2007, 120(Suppl. 2):S29-S40.
-
(2007)
Thrombosis Research
, vol.120
, Issue.SUPPL. 2
-
-
White, R.H.1
Chew, H.2
Wun, T.3
-
71
-
-
84863475142
-
Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients
-
Thaler J., Ay C., Mackman N., et al. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. Journal of Thrombosis and Haemostasis 2012, 10:1363-1370.
-
(2012)
Journal of Thrombosis and Haemostasis
, vol.10
, pp. 1363-1370
-
-
Thaler, J.1
Ay, C.2
Mackman, N.3
-
72
-
-
67949117225
-
Microparticle-associated tissue factor activity in cancer patients with and without thrombosis
-
Tesselaar M.E., Romijn F.P., van dL.I., Bertina R.M., Osanto S. Microparticle-associated tissue factor activity in cancer patients with and without thrombosis. Journal of Thrombosis and Haemostasis 2009, 7:1421-1423.
-
(2009)
Journal of Thrombosis and Haemostasis
, vol.7
, pp. 1421-1423
-
-
Tesselaar, M.E.1
Romijn, F.P.2
van, dL.I.3
Bertina, R.M.4
Osanto, S.5
-
73
-
-
72549102588
-
Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy
-
Zwicker J.I., Liebman H.A., Neuberg D., et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clinical Cancer Research 2009, 15:6830-6840.
-
(2009)
Clinical Cancer Research
, vol.15
, pp. 6830-6840
-
-
Zwicker, J.I.1
Liebman, H.A.2
Neuberg, D.3
-
74
-
-
79955941687
-
Circulating procoagulant microparticles in cancer patients
-
Thaler J., Ay C., Weinstabl H., et al. Circulating procoagulant microparticles in cancer patients. Annals of Hematology 2011, 90:447-453.
-
(2011)
Annals of Hematology
, vol.90
, pp. 447-453
-
-
Thaler, J.1
Ay, C.2
Weinstabl, H.3
-
75
-
-
20444433198
-
In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: modulation by lower-dose chemotherapy
-
Ma L., Francia G., Viloria-Petit A., et al. In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: modulation by lower-dose chemotherapy. Cancer Research 2005, 65:5365-5373.
-
(2005)
Cancer Research
, vol.65
, pp. 5365-5373
-
-
Ma, L.1
Francia, G.2
Viloria-Petit, A.3
-
76
-
-
63049125016
-
Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes
-
Swystun L.L., Shin L.Y., Beaudin S., Liaw P.C. Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes. Journal of Thrombosis and Haemostasis 2009, 7:619-626.
-
(2009)
Journal of Thrombosis and Haemostasis
, vol.7
, pp. 619-626
-
-
Swystun, L.L.1
Shin, L.Y.2
Beaudin, S.3
Liaw, P.C.4
-
77
-
-
84866159092
-
Clinical significance of circulating microparticles for venous thromboembolism in cancer patients
-
Thaler J., Ay C., Pabinger I. Clinical significance of circulating microparticles for venous thromboembolism in cancer patients. Hamostaseologie 2012, 32:127-131.
-
(2012)
Hamostaseologie
, vol.32
, pp. 127-131
-
-
Thaler, J.1
Ay, C.2
Pabinger, I.3
-
78
-
-
13244252408
-
Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score
-
Zakai N.A., Wright J., Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. Journal of Thrombosis and Haemostasis 2004, 2:2156-2161.
-
(2004)
Journal of Thrombosis and Haemostasis
, vol.2
, pp. 2156-2161
-
-
Zakai, N.A.1
Wright, J.2
Cushman, M.3
-
79
-
-
73049084524
-
Mean platelet volume is a risk factor for venous thromboembolism: the Tromso Study, Tromso, Norway
-
Braekkan S.K., Mathiesen E.B., Njolstad I., Wilsgaard T., Stormer J., Hansen J.B. Mean platelet volume is a risk factor for venous thromboembolism: the Tromso Study, Tromso, Norway. Journal of Thrombosis and Haemostasis 2010, 8:157-162.
-
(2010)
Journal of Thrombosis and Haemostasis
, vol.8
, pp. 157-162
-
-
Braekkan, S.K.1
Mathiesen, E.B.2
Njolstad, I.3
Wilsgaard, T.4
Stormer, J.5
Hansen, J.B.6
-
80
-
-
0037182012
-
Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology
-
Tsai A.W., Cushman M., Rosamond W.D., Heckbert S.R., Polak J.F., Folsom A.R. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Archives of Internal Medicine 2002, 162:1182-1189.
-
(2002)
Archives of Internal Medicine
, vol.162
, pp. 1182-1189
-
-
Tsai, A.W.1
Cushman, M.2
Rosamond, W.D.3
Heckbert, S.R.4
Polak, J.F.5
Folsom, A.R.6
-
81
-
-
73049084718
-
High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
-
Simanek R., Vormittag R., Ay C., et al. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Journal of Thrombosis and Haemostasis 2010, 8:114-120.
-
(2010)
Journal of Thrombosis and Haemostasis
, vol.8
, pp. 114-120
-
-
Simanek, R.1
Vormittag, R.2
Ay, C.3
-
82
-
-
43449115194
-
Development and validation of a predictive model for chemotherapy-associated thrombosis
-
Khorana A.A., Kuderer N.M., Culakova E., Lyman G.H., Francis C.W. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008, 111:4902-4907.
-
(2008)
Blood
, vol.111
, pp. 4902-4907
-
-
Khorana, A.A.1
Kuderer, N.M.2
Culakova, E.3
Lyman, G.H.4
Francis, C.W.5
-
83
-
-
77955714969
-
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy
-
Connolly G.C., Khorana A.A., Kuderer N.M., Culakova E., Francis C.W., Lyman G.H. Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy. Thrombosis Research 2010, 126:113-118.
-
(2010)
Thrombosis Research
, vol.126
, pp. 113-118
-
-
Connolly, G.C.1
Khorana, A.A.2
Kuderer, N.M.3
Culakova, E.4
Francis, C.W.5
Lyman, G.H.6
-
84
-
-
0035498663
-
Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma
-
Kasuga I., Makino S., Kiyokawa H., Katoh H., Ebihara Y., Ohyashiki K. Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer 2001, 92:2399-2405.
-
(2001)
Cancer
, vol.92
, pp. 2399-2405
-
-
Kasuga, I.1
Makino, S.2
Kiyokawa, H.3
Katoh, H.4
Ebihara, Y.5
Ohyashiki, K.6
-
85
-
-
24944442592
-
Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the Steering Committee of the European Association for Palliative Care
-
Maltoni M., Caraceni A., Brunelli C., et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the Steering Committee of the European Association for Palliative Care. Journal of Clinical Oncology 2005, 23:6240-6248.
-
(2005)
Journal of Clinical Oncology
, vol.23
, pp. 6240-6248
-
-
Maltoni, M.1
Caraceni, A.2
Brunelli, C.3
-
86
-
-
0035184527
-
Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance
-
Ruka W., Rutkowski P., Kaminska J., Rysinska A., Steffen J. Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance. Annals of Oncology 2001, 12:1423-1432.
-
(2001)
Annals of Oncology
, vol.12
, pp. 1423-1432
-
-
Ruka, W.1
Rutkowski, P.2
Kaminska, J.3
Rysinska, A.4
Steffen, J.5
-
87
-
-
34248218014
-
Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial
-
Schmidt H., Suciu S., Punt C.J., et al. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial. Journal of Clinical Oncology 2007, 25:1562-1569.
-
(2007)
Journal of Clinical Oncology
, vol.25
, pp. 1562-1569
-
-
Schmidt, H.1
Suciu, S.2
Punt, C.J.3
-
88
-
-
55549112598
-
Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry
-
Trujillo-Santos J., Di Micco P., Iannuzzo M., et al. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry. Thrombosis and Haemostasis 2008, 100:905-911.
-
(2008)
Thrombosis and Haemostasis
, vol.100
, pp. 905-911
-
-
Trujillo-Santos, J.1
Di Micco, P.2
Iannuzzo, M.3
-
89
-
-
84862115634
-
Risk assessment for cancer-associated thrombosis: what is the best approach?
-
Khorana A.A. Risk assessment for cancer-associated thrombosis: what is the best approach?. Thrombosis Research 2012, 129(Suppl. 1):S10-S15.
-
(2012)
Thrombosis Research
, vol.129
, Issue.SUPPL. 1
-
-
Khorana, A.A.1
-
90
-
-
84861732267
-
Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the 'SENDO experience'
-
Mandala M., Clerici M., Corradino I., et al. Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the 'SENDO experience'. Annals of Oncology 2012, 23:1416-1421.
-
(2012)
Annals of Oncology
, vol.23
, pp. 1416-1421
-
-
Mandala, M.1
Clerici, M.2
Corradino, I.3
-
91
-
-
80052751246
-
High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis
-
Moore R.A., Adel N., Riedel E., et al. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. Journal of Clinical Oncology 2011, 29:3466-3473.
-
(2011)
Journal of Clinical Oncology
, vol.29
, pp. 3466-3473
-
-
Moore, R.A.1
Adel, N.2
Riedel, E.3
-
92
-
-
84862227188
-
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
-
Verso M., Agnelli G., Barni S., Gasparini G., Labianca R. A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. Internal and Emergency Medicine 2012, 7:291-292.
-
(2012)
Internal and Emergency Medicine
, vol.7
, pp. 291-292
-
-
Verso, M.1
Agnelli, G.2
Barni, S.3
Gasparini, G.4
Labianca, R.5
-
93
-
-
84866025241
-
Venous thromboembolism (VTE) prevention with semuloparin in cancer patients initiating chemotherapy: benefit-risk assessment by VTE risk in SAVE-ONCO [abstract 206]
-
George D., Agnelli G., Fisher W., et al. Venous thromboembolism (VTE) prevention with semuloparin in cancer patients initiating chemotherapy: benefit-risk assessment by VTE risk in SAVE-ONCO [abstract 206]. Blood 2011, 118.
-
(2011)
Blood
, vol.118
-
-
George, D.1
Agnelli, G.2
Fisher, W.3
-
94
-
-
84857129296
-
Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer
-
Agnelli G., George D.J., Kakkar A.K., et al. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. New England Journal of Medicine 2012, 366:601-609.
-
(2012)
New England Journal of Medicine
, vol.366
, pp. 601-609
-
-
Agnelli, G.1
George, D.J.2
Kakkar, A.K.3
-
96
-
-
70449724622
-
Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines
-
Petersen L.J. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines. Cancer Treatment Reviews 2009, 35:754-764.
-
(2009)
Cancer Treatment Reviews
, vol.35
, pp. 754-764
-
-
Petersen, L.J.1
-
97
-
-
36849070772
-
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer
-
Lyman G.H., Khorana A.A., Falanga A., et al. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. Journal of Clinical Oncology 2007, 25:5490-5505.
-
(2007)
Journal of Clinical Oncology
, vol.25
, pp. 5490-5505
-
-
Lyman, G.H.1
Khorana, A.A.2
Falanga, A.3
-
98
-
-
84856699090
-
Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
-
Guyatt G.H., Akl E.A., Crowther M., Gutterman D.D., Schuunemann H.J. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012, 141:7S-47S.
-
(2012)
Chest
, vol.141
-
-
Guyatt, G.H.1
Akl, E.A.2
Crowther, M.3
Gutterman, D.D.4
Schuunemann, H.J.5
-
99
-
-
77955496152
-
Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines
-
Lyman G.H., Kuderer N.M. Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines. Thrombosis Research 2010, 125(Suppl. 2):S120-S127.
-
(2010)
Thrombosis Research
, vol.125
, Issue.SUPPL. 2
-
-
Lyman, G.H.1
Kuderer, N.M.2
-
100
-
-
84857128698
-
Routine heparin for patients with cancer? One answer, more questions
-
Akl E.A., Schunemann H.J. Routine heparin for patients with cancer? One answer, more questions. New England Journal of Medicine 2012, 366:661-662.
-
(2012)
New England Journal of Medicine
, vol.366
, pp. 661-662
-
-
Akl, E.A.1
Schunemann, H.J.2
|